VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior to January 2023 and after January 2023. This study is one of a kind, as no other comparative retrospective chart review on the performance of VASCU-GUARD vascular patches from the old and new packaging has been published yet. The project will contribute to the scientific knowledge about long-term outcomes associated with the use of patch material during endarterectomies.
Study Type
OBSERVATIONAL
Enrollment
500
carotid endarterectomy (CEA) with the use of Baxter VASCU-GUARD vascular patches
Houston Methodist Hospital
Houston, Texas, United States
Ultrasound evaluation of Baxter VASCU-GUARD vascular patches
Retrospective review of ultrasound recordings and ultrasound reports at one-month, 3-months, 6-months and 1-year follow-up after endarterectomy - if available, to evaluate patch patency, morphology, integrity, complications, and blood flow dynamics
Time frame: 1/1/2023 - 4/30/2024
Complications assessment
Analyze complications linked with Baxter Vascular Patches (VASCU-GUARD), including but not limited to thrombosis, stroke, dissection, restenosis, infection, fluid collection, pseudoaneurysm formation, fraying or irregularities in patch material.
Time frame: 1/1/2023 - 4/30/2024
Correlation with Clinical Outcomes
Recognize correlations between ultrasound findings and clinical outcomes. This correlation will complement the understanding of how ultrasound monitoring can predict and influence patient prognosis.
Time frame: 1/1/2023 - 4/30/2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.